ASIA unversity:Item 310904400/16221
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 90570/105786 (86%)
造访人次 : 16405611      在线人数 : 193
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/16221


    题名: BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment.
    作者: ;Woodward, W.A.,;Yu, D.,;Hortobagyi, G.N.;洪明奇;Hung, Mien-Chie
    贡献者: 生物科技學系
    日期: 2012
    上传时间: 2012-11-23 17:10:07 (UTC+8)
    摘要: "Breast cancer initiating cells (BCICs), which can fully recapitulate the tumor origin and are often resistant to
    chemo- and radiotherapy, are currently considered as a major obstacle for breast cancer treatment. Here, we
    show that BIKDD, a constitutively active mutant form of proapoptotic gene, BIK, effectively induces
    apoptosis of breast cancer cells and synergizes with lapatinib. Most importantly, BikDD significantly reduces
    BCICs through co-antagonism of its binding partners Bcl-2, Bcl-xL, and Mcl-1, suggesting a potential
    therapeutic strategy targeting BCICs. Furthermore, we developed a cancer-specific targeting approach for
    breast cancer that selectively expresses BikDD in breast cancer cells including BCICs, and demonstrated
    its potent antitumor activity and synergism with lapatinib in vitro and in vivo."
    關聯: CANCER CELL
    显示于类别:[生物科技學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML265检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈